Guzman Pablo A. 4
4 · ZyVersa Therapeutics, Inc. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
Guzman Pablo A.
Chief Medical Officer
Transactions
- Award
Stock Options (right to buy)
2023-01-26+100,000→ 100,000 totalExercise: $2.11Exp: 2033-01-26→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests in 3 equal annual installments commencing on January 26, 2024.